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A B S T R A C T
Background: Only about half of people with obsessive compulsive disorder (OCD) show clinically signiﬁcant
improvement following the recommended therapy, exposure and response prevention (ERP), partly due to poor
therapy acceptability. A mindfulness-based approach to ERP (MB-ERP) has the potential to improve accept-
ability and outcomes.
Methods: This was an internal pilot randomised controlled trial (RCT) of group MB-ERP compared to group ERP.
37 participants meeting DSM-IV OCD criteria were randomly allocated to MB-ERP or ERP.
Results: Both groups improved in OCD symptom severity. However, MB-ERP did not lead to clinically important
improvements in OCD symptom severity at post-intervention compared to ERP – the minimum clinically im-
portant diﬀerence was not contained in the 95% conﬁdence intervals. There were negligible between-group
diﬀerences in engagement and MB-ERP did not appear to have broader beneﬁts compared to ERP on depression,
wellbeing or OCD-related beliefs. Conversely, MB-ERP led to medium/medium-large improvements in mind-
fulness compared to ERP.
Conclusions: MB-ERP is unlikely to lead to clinically meaningful improvements in OCD symptom severity
compared to ERP alone. We underline the importance of adhering to treatment guidelines recommending ERP
for OCD. Insuﬃcient attention may have been given to mindfulness practice/discussion in MB-ERP and further
research is recommended to explore this possibility.
1. Introduction
Obsessive compulsive disorder (OCD) is characterised by persistent
intrusive thoughts that cause signiﬁcant anxiety and repetitive beha-
viours aimed at neutralising anxiety or preventing a dreaded event
(American Psychiatric Association, 2013). OCD has a lifetime pre-
valence of 0.7–2.5 percent (Crino, Slade, & Andrews, 2005) and is as-
sociated with poor quality of life (Macy et al., 2013).
Practice guidelines recommend exposure and response prevention
(ERP), delivered with or without cognitive therapy, as the psycholo-
gical therapy for OCD (American Psychiatric Association, 2007;
National Institute of Health and Care Excellence [NICE], 2005). Whilst
ERP is eﬀective for OCD, around 50% of people do not recover after
therapy (Öst, Havnen, Hansen, & Kvale, 2015).
Exposure-based therapies are theorised to work through habituation
to the obsession (Ponniah, Magiati, & Hollon, 2013) and/or through
inhibitory learning, i.e. strengthening competing non-fear memories
about the feared object/event (Craske, Treanor, Conway, Zbozinek, &
Vervliet, 2014). Frequent, repeated exposure tasks are required for both
these processes to occur, with inhibitory learning theory emphasising
the context-speciﬁc nature of new learning (Craske et al., 2014). Re-
covery is therefore unlikely in the absence of frequent, repeated ERP
tasks performed in various contexts. By deﬁnition ERP is anxiety-pro-
voking and yet, people with OCD can be particularly intolerant of an-
xiety (Cougle, Timpano, Fitch, & Hawkins, 2011; Olatunji, Deacon, &
Abramowitz, 2009). It has been suggested that poor engagement with
ERP might explain disappointing recovery rates. Indeed, a naturalistic
study found that 25% of adults with OCD refused CBT despite profes-
sional recommendation (Mancebo, Eisen, Sibrava, Dyck, & Rasmussen,
2011) whilst Öst et al., Öst et al. (2015) reported a 19.1% dropout rate
for ERP. Even when people complete a course of ERP, task engagement
may be insuﬃcient to achieve recovery. For example, Simpson et al.
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(2011) found that adherence to between-session ERP tasks signiﬁcantly
predicted treatment outcome and that adherence had to be high
(75–90% of all ERP task assignments) to achieve a clinically signiﬁcant
change in OCD symptoms.
Enhancing the acceptability of ERP might increase engagement and
thereby improve outcomes. Mindfulness can be deﬁned as “paying at-
tention in a particular way: on purpose, in the present moment, and
nonjudgmentally” (Kabat-Zinn, 1994) (p. 4). It can be cultivated
through mindfulness practice to increase non-judgemental awareness
and skills in responding to thoughts and feelings (Bishop, 2004).
Mindfulness-based interventions (MBIs) have demonstrated positive
outcomes for clinical populations with a broad range of mental health
diﬃculties (Khoury et al., 2013; Kuyken et al., 2016; Strauss, Cavanagh,
Oliver, & Pettman, 2014). Preliminary evidence suggests that MBIs
could also beneﬁt OCD (Hale, Strauss, & Taylor, 2013; Key, Rowa,
Bieling, McCabe, & Pawluk, 2017). Metacognitive Therapy is an ap-
proach with some theoretical and therapeutic similarities to MBIs
(Wells, 1997). In the treatment of OCD, metacognitive beliefs about
intrusive thoughts are identiﬁed and reappraised and what is termed
‘detached mindfulness’ exercises are practiced. This involves noticing
intrusive thoughts and allowing them to naturally pass without enga-
ging with them. Preliminary research on Metacognitive Therapy for
OCD suggests it can lead to clinically important changes in symptom
severity (Fisher & Wells, 2008). Whilst MBIs and related approaches has
potential in the treatment of OCD there is a risk that the beneﬁts of ERP
are lost in these novel approaches. Given the strength of evidence for
ERP (Öst et al., 2015), we suggest combining an MBI with ERP has the
greatest potential to provide beneﬁt.
The present study proposes that a mindfulness-based approach to
ERP (MB-ERP) could enhance engagement in ERP and improve out-
comes for three reasons. First, through mindfulness practice and dis-
cussion, MBIs invite and support people to allow thoughts into aware-
ness with acceptance, and without judging or attempting to suppress
them (Segal, Williams, & Teasdale, 2013). Whilst traditional ERP in-
volves exposure to intrusive thoughts as a core part of the therapy,
strategies to facilitate exposure to intrusive thoughts are not well es-
tablished and may in part explain poor rates of ERP task engagement.
We suggest that guided mindfulness practice could enable people to
fully exposure to intrusive thoughts. In-the-moment verbal guidance is
given during mindfulness practice in session and between-session
mindfulness practice is supported through the use of audio recordings.
The verbal guidance encourages noticing and sitting with diﬃcult
thoughts as they arise with curiosity and acceptance. Therefore MB-ERP
could enable people to expose to and accept intrusive thoughts and to
remain engaged in ERP tasks despite such thoughts. Second, people
with OCD have a heightened intolerance of anxiety (Cougle et al.,
2011). This is particularly problematic for ERP which by deﬁnition is an
anxiety-provoking intervention. Whilst traditional ERP encourages
people to stay with feelings of anxiety during tasks as a core part of the
intervention, strategies that enable people to do this are not well un-
derstood and may well explain poor rates of engagement with ERP
tasks. We suggest that a mindfulness-based approach could provide a
means to cultivate the ability to sit with high levels of anxious arousal.
Guided mindfulness practice invites people to carefully observe and
accept unpleasant physical sensations of anxiety with a sense of kind-
ness and curiosity, and in-the-moment verbal guidance may be parti-
cularly important when cultivating this ability in the face of present-
moment anxiety (Segal et al., 2013). Therefore, MB-ERP could provide
a means through which people are better able to attend to and accept
these sensations during ERP tasks and nevertheless, sustain task en-
gagement. Third, MBIs encourage people to be aware of behavioural
choices available in response to an event, rather than reacting auto-
matically (Segal et al., 2013).Guidance oﬀered during mindfulness
practice draws attention to in-the-moment behavioural choices that
may otherwise go unnoticed. We suggest that this may help to cultivate
the ability to notice and choose how best to respond to compulsive
urges rather than reacting to them automatically. MB-ERP could
therefore help people to consciously choose to resist urges to engage in
compulsions during ERP tasks.
In line with MRC guidance in the UK on the sequential phases of
development of RCTs for complex interventions (Medical Research
Council, 1998) and from the National Institute for Health Research in
the UK (National Institute for Health Research, 2017), this study was an
internal pilot RCT conducted in anticipation of a deﬁnitive trial that
examines whether group MB-ERP is more eﬀective at reducing OCD
symptom severity and better at enhancing therapy engagement than
standard group ERP for people with OCD. An internal pilot RCT is a
smaller version of a fully powered deﬁnitive trial that is run prior to the
deﬁnitive trial to check trial procedures are running smoothly and to
estimate the sample size required for the deﬁnitive trial, and indeed to
determine if a deﬁnitive trial is warranted (National Institute for Health
Research, 2017). The primary aim of this internal pilot study was to
estimate the size and direction of the potential treatment eﬀect, and the
corresponding 95% conﬁdence interval, by comparing MB-ERP groups
to standard ERP groups on the primary outcome measures of OCD
symptom severity and therapy engagement. Measures of other outcome
(depression and wellbeing) and process (mindfulness and obsessive-
compulsive beliefs) were included.
A deﬁnitive trial of the same study design was planned if the di-
rection of potential treatment eﬀect was in favour of MB-ERP over ERP.
Hypotheses for the deﬁnitive trial would be that MB-ERP in comparison
to ERP would lead to greater improvements in OCD symptom severity
at post-intervention (primary hypothesis), and that this would be
mediated by greater engagement with ERP tasks. Greater improvements
in depression symptom severity and wellbeing (secondary hypotheses)
and greater improvements in mindfulness and obsessive-compulsive
beliefs (process hypotheses) for MB-ERP in comparison to ERP would
also be hypothesised.
2. Material method
2.1. Design and sample size
This is an internal pilot for a pragmatic single centre, assessor-blind,
superiority RCT, with two parallel-groups and 1:1 allocation to either
MB-ERP or ERP alone. The trial was registered prior to recruitment
commencing (ISRCTN52684820. Registered on 30 January 2014) and
the therapy protocol was published prior to recruitment ending ([au-
thor names removed to preserve anonymity]). This study received
ethical approval through the South East Coast (Surrey) arm of the
National Research Ethics System in the UK (reference: 13/LO/1768).
Recruitment occurred between March 2014 and January 2015.
2.2. Participants
Inclusion criteria were that participants: (1) met DSM-IV (American
Psychiatric Association, 2013) diagnostic criteria for OCD based on the
Mini International Neuropsychiatric Interview [MINI 6.0.0] (Sheehan
et al., 2010); (2) were stable on psychiatric medication for at least 3
months prior to consent; (3) had no plans for changing psychiatric
medication during the study; (4) had not received psychological
therapy in the past three months and had no plans for commencing
therapy during the study; and (5) were 18 years or older. It should be
noted that the DSM-IV version of the MINI (6.0.0) was used as the DSM-
5 version (MINI 7.0.0) was not available at the time of recruitment.
People were excluded if they had an identiﬁed organic cause for
their OCD symptoms, a diagnosed learning disability, or met DSM-IV
diagnostic criteria for a psychotic disorder, post-traumatic stress dis-
order (PTSD), anorexia nervosa, alcohol abuse or substance abuse based
on MINI 6.0.0 interview (Sheehan et al., 2010). Psychosis, anorexia and
PTSD were exclusion criteria because of concerns that mindfulness
practice can heighten distress or exacerbate symptoms in the face of
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psychotic experiences, bodily sensations and cognitions associated with
anorexia and in the face of intrusive traumatic memories. Research
exploring the safety of MBIs in these populations is limited and as such
they were added as exclusion criteria. People with hoarding-only
compulsions were excluded as this is no longer considered a subtype of
OCD (American Psychiatric Association, 2013).
2.3. Procedure
Recruitment occurred in two sites within an NHS Mental Health
Trust in the South of the England. The research assistant completed
baseline assessments within four weeks of the therapy groups starting.
Following the baseline assessment, participants were randomly allo-
cated to an MB-ERP or an ERP group. Measures were taken at baseline
(Time 1), post-therapy (Time 2) and at 6-months post-therapy (Time 3).
2.4. Interventions
Further details of the intervention protocols are in the published
protocol ([author names removed to preserve anonymity]). To mini-
mise therapist eﬀects all therapy sessions (MB-ERP and ERP) were fa-
cilitated by the same two clinical psychologists, one of whom was an
accredited Cognitive Behavioural Therapy (CBT) therapist and accre-
dited MBCT teacher. Supervision was provided for both group facil-
itators by an expert in ERP. Mindfulness supervision was provided by an
accredited MBCT supervisor
2.4.1. ERP groups
The ERP group consisted of 10 two-hour sessions based on treat-
ment recommendations derived from inhibitory learning theory
(Abramowitz & Arch, 2014; Arch & Abramowitz, 2015). Session 1 in-
troduced the rationale for ERP. Sessions 2–9 involved participants de-
signing in-vivo and between-session ERP tasks. Participants were
strongly encouraged to engage in their planned ERP tasks at least daily
between group sessions and to use their ERP daily diaries to monitor
engagement with tasks. Participants were also encouraged to conduct
unplanned ERP tasks in daily life when facing obsessional cues. Session
10 focused on consolidating learning. If a participant missed a session
they were contacted by phone by one of the group facilitators im-
mediately after the session to explore reasons for missing the session
and to identify and plan daily ERP tasks.
2.4.2. MB-ERP groups
The MB-ERP group consisted of 10 two-hour sessions. Session 1
introduced the rationale for ERP alongside the rationale for including
mindfulness. Sessions 2–9 each began with a 10-min guided mind-
fulness practice: mindfulness of the breath and body (session 1);
mindfulness of the breath, body, sounds and (intrusive) thoughts (ses-
sions 2–3); mindfulness of (intrusive) thoughts (session 4–5); and
mindfulness of body, (intrusive) thoughts, urges and action (sessions
6–10). Verbal guidance for the mindfulness practice was developed
particularly for this study by an expert in MBIs and OCD, focusing on
the three mechanisms outlined earlier: (1) mindfulness of intrusive
thoughts, (2) mindfulness of body sensations of anxiety, and (3)
mindfulness of compulsive urges. The guidance diﬀered to that found in
MBCT and other related approaches. The verbal guidance explicitly
invited people to notice intrusive thoughts, bodily sensations associated
with intrusive thoughts/anxiety and compulsive urges and to bring a
sense of acceptance to these experiences. Mindfulness practices were
followed by a 20-min Socratic inquiry. A three-minute mindfulness
breathing space practice (Segal, Williams, & Teasdale, 2002) was also
introduced from session 6 onwards. The ﬁnal 90min of MB-ERP session
followed the same ERP protocol outlined above. During ERP tasks,
participants were encouraged to bring mindfulness to the tasks. Session
10 focused on consolidating learning from the therapy. If a participant
missed a session they were contacted by phone by one of the group
facilitators immediately after the session to explore reasons for missing
the session, to identify and plan daily ERP tasks and to support con-
tinued home mindfulness practice.
2.5. Outcome measures
2.5.1. Therapy ﬁdelity
Therapy sessions were audio recorded and three randomly selected
sessions from each group in each site were rated for ﬁdelity to the re-
levant protocol (MB-ERP or ERP) by an OCD expert. Each element of
the therapy protocol was scored on a 0–2 scale (0= element not pre-
sent; 1= element partially present; 2= element fully present) and total
percentage ﬁdelity calculated.
2.5.2. Diagnostic status
The Mini International Neuropsychiatric Interview (MINI version 6.0.0)
(Sheehan et al., 2010). DSM-IV OCD diagnosis was established at all
time points using the OCD section of the MINI 6.0.0. At baseline, in
order to determine possible reasons for exclusion, the MINI 6.0.0 was
also administered for psychotic disorder, post-traumatic stress disorder,
anorexia nervosa, alcohol abuse or substance abuse.
2.5.3. Primary outcome measures
Yale-Brown Obsessive Compulsive Scale – Second Edition (YBOCS-II)
(Goodman, Rasmussen, Price, & Storch, 2006). The YBOCS-II is a
measure of OCD symptom severity and has excellent indices of relia-
bility and validity (Storch et al., 2010). The overall score for YBOCS-II
varies between 0 and 50 with ten items, each rated on a 0–5 scale, with
higher scores indicating greater OCD symptom severity. A minimum
clinically important diﬀerence (MCID) of 5 would represent an average
diﬀerence of 0.5 per item. This was determined through consultation
with the Lived Experience Advisory Panel (LEAP) for the study who
provided consultation during the development and implementation of
the trial. The LEAP suggested that an average improvement of half a
point per item on the YBOCS-II would constitute a meaningful level of
improvement.
ERP engagement. Engagement was measured as: (1) the number of
therapy sessions attended (0–10), and (2) the number of ERP tasks
performed between sessions. Participants were given daily diaries to
record ERP home tasks.
2.5.4. Secondary outcome measures
Short Warwick-Edinburgh Mental Well-Being Scale (Stewart-Brown
et al., 2009). This is a 7-item measure of well-being with items rated on
a 5-point scale (items rated 1–5). A higher score indicates greater
wellbeing. Stewart-Brown et al. (2011) reported strong internal con-
sistency, test re-test reliability, and concurrent validity and found that
the measure is sensitive to change in mental health populations.
Beck Depression Inventory – second edition (BDI-II) (Beck, Steer, &
Brown, 1996). The BDI-II is a 21-item measure of depressive symptom
severity with items rated on a 4-point (0–3) scale. Higher scores in-
dicate greater depressive symptom severity. It has excellent internal
consistency and test re-test reliability (α > 0.9 for both). Concurrent
validity with the Hamilton Psychiatric Rating Scale for Depression-
Revised is good (r= 0.71).
Five-Facet Mindfulness Questionnaire – Short Form (FFMQ-SF) (Baer,
Smith, Hopkins, Krietemeyer, & Toney, 2006; Bohlmeijer, ten Klooster,
Fledderus, Veehof, & Baer, 2011). The FFMQ-SF is a 24-item self-report
scale assessing ﬁve mindfulness factors: observing, describing, acting
with awareness, non-judgement and non-reacting. Items are rated on a
5-point (1–5) scale and higher subscale/scale totals indicate greater
levels of mindfulness. The short form has adequate indices of reliability
(α > .73 for each subscale) and validity (Bohlmeijer et al., 2011).
Obsessional Beliefs Questionnaire − Revised (OBQ-44) (Obsessive
Compulsive Cognitions Working Group, 2005). The OBQ-44 is a 44-
item self-report measure of OCD-related cognitions with items rated on
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a 7-point (1–7 scale). Higher scores indicate greater endorsement of
problematic OCD-related cognitions. The instrument has three sub-
scales: (1) Responsibility/Threat Estimation, (2) Perfectionism/Cer-
tainty, and (3) Importance/Control of thoughts. The scales have ex-
cellent internal consistency (α > .89 for each subscale), and the total
score on the OBQ-44 distinguishes between people diagnosed with OCD
and non-OCD anxious controls (OCCWG, 2005).
2.5.5. Attrition
Attrition was deﬁned as the number of participants dropping out of
the study for each study arm and at each time point.
2.6. Stop/go criteria
In order to proceed to a deﬁnitive trial, the between-group post-
intervention diﬀerence on the YBOCS-II would need to be greater than
0 in favour of MB-ERP and the 95% CI for this eﬀect would need to
include the minimum clinically important diﬀerence (MCID) of 5
points.
2.7. Sample size
The sample size for this study was based on the recommended
minimum of 12 completer participants per arm for a pilot RCT (Julious,
2005). We aimed to recruit approximately 20 people per arm to con-
servatively allow for up to 40% attrition.
2.8. Randomisation and blinding
To conceal allocation from the research team, an online randomi-
sation system was set up by the independent Clinical Trials Unit (CTU)
using 1:1 allocation to either an ERP group or a MB-ERP group using
blocks of size two. The CTU were blind to participant details. A research
assistant enrolled participants and assigned them to interventions
through the CTU online system. The ﬁrst and second set of groups took
place in the two sites seven months apart. Post-therapy and six-month
follow-up assessments were completed by a research assistant blind to
treatment allocation. Breaches to research assistant blinding were ad-
dressed by recruiting another blinded research assistant to conduct the
assessment. All participants were blind to study hypotheses.
2.9. Data & safety monitoring
During the study three Trial Steering Committee meetings were held
to discuss the study’s progress and report any adverse events. Data
quality assurance was overseen by the trial statistician who co-ordi-
nated a data checking process where 16% of the study data was re-
entered by a research assistant external to the study and then checked
for inconsistencies.
2.10. Data analysis
In line with the advice and guidance in the literature for evaluating
pilot RCTs we did not carry out any hypothesis tests because the study
was not intended or powered to detect statistically signiﬁcant eﬀects
(Leon, Davis, & Kraemer, 2011). In pilot trials the guidance is only to
report descriptive statistics (Lee, Whitehead, Jacques, & Julious, 2014).
We report descriptive statistics for all participant characteristics and
clinical outcomes in the form of counts, proportions, means, standard
deviations and ranges as appropriate. Analysis was carried out on an
intention-to-treat principle so all participant data was analysed ac-
cording to their randomisation allocation. We were also interested in
estimating treatment eﬀects to look for an indication of potential su-
periority of the MB-ERP over ERP treatment on the primary outcome.
Treatment eﬀects were calculated at both post-therapy and the six-
month follow-up time points separately using Linear Regression with
the clinical measure as the outcome. Treatment group (ERP or MB-ERP)
was entered into the regression as a factor and baseline clinical mea-
sures were entered as covariates. Corresponding 95% conﬁdence in-
tervals were calculated for all treatment eﬀects. As the analysis was
exploratory, no corrections were made for missing data in the analysis.
Cohen’s d was calculated from the unstandardized estimate of the be-
tween group diﬀerence divided by the pooled baseline standard de-
viation.
3. Results
3.1. Participant and study characteristics
The consort diagram (Fig. 1) shows the trial proﬁle. In total, 37
participants were randomised to an MB-ERP (n=19) or ERP (n=18)
group. One person was screened out due to meeting exclusion criteria.
Participant characteristics are shown in Table 1. All baseline participant
characteristics were similar between groups.
Study retention was good at post-therapy: 86% of participants were
followed up post-therapy and drop-outs totalled 1 (5.6%) participant in
the ERP group and 4 (21%) in the MB-ERP group. The 6-months follow-
up rate of 65% was below target; 6 (33%) participants dropped out
from the ERP group and 7 (37%) from MB-ERP.
Data completeness for participants retained in the study was 97% at
post-therapy and 87% at follow-up. The lower level of data complete-
ness at follow-up was due to 3 (13%) participants providing incomplete
scores on parts of the OBQ. On the primary outcome, data was only
missing due to non-collection for 1 (4%) participant at follow-up.
Homework data collection was poor with 72% and 55% of weekly
ERP homework diaries missing in the ERP and MB-ERP groups, re-
spectively. In addition, 63% of the mindfulness diaries were missing in
the MB-ERP group.
3.2. Main outcomes
3.2.1. OCD symptom severity
Table 2 shows the distribution of clinical outcomes by study arm by
time point. At baseline, the distribution of YBOCS-II was similar in the
two study arms with a mean of 29.1 (SD 6; range 19–40) in the MB-ERP
group and 29.8 (SD 7.6; range 13–46) in the ERP group. Any between-
group diﬀerences for all clinical outcomes were negligible at baseline.
The post-therapy distributions of the YBOCS-II indicated mean pre-
Referred (n=63)
MB-ERP
Completed T1 assessment (n=15)
Unable to contact for T1 (n=4) 
Allocated to MB-ERP (n=19)
ERP
Completed T1 assessment (n=17)
Unable to contact for T1 (n=1) 
Allocated to ERP (n=18)
Allocation
Post-intervention Assessment (T1)
Randomized (n=37)
Enrollment
MB-ERP
Completed T2 assessment (n=12)
Unable to contact for T2 (n=7) 
ERP
Completed T2 assessment (n=12)
Unable to contact for T2 (n=6) 
6-Month Follow-up (T2)
Assessed (n=38)
Excluded for not meeting 
eligibility criteria (n=1)
Fig. 1. CONSORT Diagram showing participant ﬂow through the study.
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post therapy change in both study arms of 6.1 points in the MB-ERP arm
and 9.1 points in ERP which increased from pre-therapy to six-month
follow-up:10.8 points in the MB-ERP arm and 11.3 points in the ERP
arm.
Table 3 shows estimated eﬀect sizes for each clinical outcome by
time point. At post-intervention, the between-group diﬀerence was 2.4
YBOCS-II points (95% CI −3.8 to 8.6) with a corresponding Cohen’s d
of 0.36 (95% CI −0.37,1.08) in favour of ERP. At 6-months follow-up
the between-group diﬀerence was 0.3 YBOCS-II points in favour of MB-
ERP (95% CI −11.4 to 10.8), Cohen’s d=−0.04 (95% CI −0.9,0.8),
suggesting negligible between-group diﬀerences. The 95% conﬁdence
interval at post-intervention excludes the minimum clinically im-
portance diﬀerence (MCID) of a ﬁve point between-group diﬀerence on
the YBOCS-II.
3.2.2. Engagement
A mean of 6.5 sessions (SD 3.4; range 0–10) out of 10 were attended
with little diﬀerence between the two groups: MB-ERP had a mean
session attendance of 6.6 (SD 3.4; range 1–10) and ERP had 6.4 (SD 3.4;
range 0–10). The average number of ERP tasks per week was 20 in the
ERP group and 16 in the MB-ERP group. On average ﬁve formal
mindfulness practices were reported each week by participants in the
MB-ERP arm.
3.2.3. Therapy ﬁdelity
Therapist ﬁdelity to the ERP and MB-ERP protocols were high at
90% and 93% respectively.
3.2.4. Secondary outcomes
Following treatment, participants in the MB-ERP condition showed
greater levels of mindfulness on all subscales of the FFMQ compared to
ERP. Between-group diﬀerences on FFMQ total was 6.0 points at post-
intervention (95% CI −1.4,13.4), a medium eﬀect (Cohen’s d=0.53)
and 7.9 points at 6-months follow-up (95% CI −1.6, 17.4), a large ef-
fect (Cohen’s d=0.70). As shown in Table 3, summary estimates of the
other secondary outcomes of wellbeing (SWEMWS) depression (BDI-II)
and OCD-related beliefs (OBQ-44) showed negligible, small or medium
between-group eﬀect sizes that were mostly but not all in favour of the
Table 1
Descriptive summary of participant characteristics.
MB-ERP N=19 ERP N=18
Gender
Female 15 79% 9 50%
Male 4 21% 9 50%
Age median years (range) 33 (21–49) 27 (18–51)
Ethnicity
White British 18 95% 18 100%
Black & Minority Ethnic 1 5% 0 0%
Site
Site 1 10 53% 9 50%
Site 2 9 47% 9 50%
Employment Status
Employed 12 63% 10 56%
Unemployed 4 21% 6 33%
Other 3 16% 2 11%
Education Level
Left school before 16 4 21% 0 0%
Left school at 16 5 26% 3 17%
Left school at 17/18 1 5% 0 0%
Completing/completed College 4 21% 6 33%
Completing/completed University 5 26% 9 50%
Marriage Status
single 12 63% 11 61%
married/civil partnership 4 21% 3 17%
cohabiting 3 16% 3 17%
separated/divorced 0 0% 1 6%
Values are numbers (percentages) unless otherwise indicated.
Table 2
Descriptive statistics of clinical outcomes by study arm and time point.
Study Arm
Measure MB-ERP ERP
N Mean (SD) N Mean (SD)
Baseline YBOCS II 19 29.11 (6.02) 18 29.83 (7.59)
T1 15 22.93 (8.15) 17 21.12 (9.78)
T2 11 17.27
(13.57)
12 18.17 (11.82)
Baseline SWEMWBS 19 17.84 (3.98) 18 18.89 (4.70)
T1 15 19.33 (5.42) 17 20.29 (4.24)
T2 11 22.00 (5.81) 12 21.50 (5.37)
Baseline BDI-II 19 25.68
(10.04)
18 25.39 (14.46)
T1 15 22.40
(14.81)
17 16.82 (12.26)
T2 12 17.08
(12.56)
11 17.18 (14.70)
FFMQ-SF
Baseline TOTAL 19 63.05 (9.97) 18 63.1 (12.77)
T1 15 74.73
(10.55)
17 69.82 (12.87)
T2 11 79.00
(11.61)
12 72.75 (15.90)
Baseline Observing 19 12.47 (3.04) 18 11.39 (4.33)
T1 15 13.07 (3.24) 17 10.59 (4.98)
T2 12 14.00 (3.16) 12 12.67 (4.92)
Baseline Describing 19 15.21 (3.36) 18 14.83 (4.45)
T1 15 16.20 (3.41) 17 16.18 (4.32)
T2 12 17.00 (2.63) 12 17.17 (4.76)
Baseline Acting with Awareness 19 12.74 (4.29) 18 14.44 (4.55)
T1 15 15.33 (3.90) 17 15.94 (4.66)
T2 12 15.92 (3.68) 12 15.75 (5.10)
Baseline Non-judging 19 11.00 (2.49) 18 12.67 (3.43)
T1 15 15.53 (3.74) 17 14.29 (3.95)
T2 11 15.64 (5.03) 12 13.92 (4.62)
Baseline Non-reacting 19 11.63 (2.45) 18 10.28 (3.23)
T1 15 14.60 (4.12) 17 12.82 (3.56)
T2 12 15.67 (4.60) 12 13.25 (4.41)
OBQ-44
Baseline Total 19 201.58
(35.35)
18 201.39
(48.85)
T1 14 174.39
(53.01)
16 157.16
(48.18)
T2 9 166.44
(59.25)
12 159.83
(38.97)
Baseline Responsibility/Threat
estimation
19 78.32
(21.20)
18 77.94 (19.39)
T1 15 68.43
(23.50)
16 63.75 (21.21)
T2 10 66.90
(24.94)
12 63.25 (23.35)
Baseline Perfectionism/Certainty 19 82.63
(16.16)
18 72.78 (25.08)
T1 15 72.93
(21.01)
16 55.03 (23.85)
T2 11 69.36
(22.73)
12 62.17 (20.67)
Baseline Importance/Control of
thoughts
19 40.63
(13.36)
18 50.67 (16.13)
T1 15 36.20
(16.41)
16 38.38 (14.52)
(continued on next page)
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ERP group compared to MB-ERP.
3.2.5. Adverse events and serious adverse events
No adverse events were reported.
4. Discussion
This was an internal pilot RCT of MB-ERP compared to standard
ERP groups not intended and underpowered to detect statistically sig-
niﬁcant eﬀects. However, the 95% conﬁdence intervals for between-
group diﬀerence in improvements in OCD symptom severity at post-
intervention did not include the minimum clinically important diﬀer-
ence (MCID) on OCD symptom severity. This means that a deﬁnitive
trial of the same design would be very unlikely to ﬁnd that MB-ERP
leads to clinically important improvements in OCD symptom severity in
comparison to ERP alone. In addition, there were negligible between-
group diﬀerences on measures of therapy engagement (session atten-
dance and homework task completion).
The study also failed to support the suggestion that the MB-ERP
protocol has potential to lead to greater improvements in OCD-related
beliefs, depression or wellbeing than ERP alone either at post-therapy
or at six-months follow-up. Although the study was underpowered to
detect statistically signiﬁcant diﬀerences, it is notable that almost all
post-intervention and follow-up scores on the measures of depression,
wellbeing and OCD-related beliefs were numerically in favour of ERP in
comparison to MB-ERP. Given that the strongest evidence for MBIs in
the context of mental health is in the treatment of depression (Kuyken
et al., 2016; Strauss et al., 2014) this may seem somewhat surprising.
However, MBIs may not be more eﬀective in the treatment of depres-
sion when compared to alternative psychological interventions with
equivalent therapist contact time (Farb et al., 2018) and therefore the
ﬁndings in the current study are perhaps not so surprising. However,
there was evidence that MB-ERP has the potential to improve mind-
fulness in comparison to ERP as between-group diﬀerences were in
favour in MB-ERP at both post-therapy and follow-up, with medium to
large eﬀect sizes.
4.1. Findings in context
This study was based on the theoretical reasons proposed for why
cultivating mindfulness might beneﬁt outcomes for ERP for OCD
(Strauss, Luke, Hayward, & Jones, 2015). First, MB-ERP with its tea-
cher-led experiential mindfulness practice was expected to enable
Table 2 (continued)
Study Arm
Measure MB-ERP ERP
N Mean (SD) N Mean (SD)
T2 12 38.50
(22.81)
12 34.42 (12.66)
Note: Exposure Response Prevention (ERP), Mindfulness Based −Exposure
Response Prevention MB-ERP; Yale-Brown Obsessive Compulsive Scale Second
Edition (YBOCS II), Short Warwick-Edinburgh Mental Well-being Scale
(SWEMWB), Five Facets of Mindfulness Questionnaire − short form (FFMQ-
SF), Beck Depression Inventory − second edition (BDI-II), Obsessional Beliefs
Questionnaire − 44 item version (OBQ-44); Standard Deviation (SD); Post
therapy (T1), 6 months follow-up (T2).
Table 3
Unstandardised and standardised between-group eﬀect sizes at post treatment and at follow-up.
Unstandardised eﬀects Standardised between-group eﬀects
Clinical Measure Time point Eﬀect size 95% CI for eﬀect size Standard Error p-value Cohen's da 95% CI for Cohen's d
YBOCS-II T1 2.40 (−3.77,8.57) 3.02 0.43 0.36 (−0.37,1.08)
T2 −0.29 (−11.39,10.82) 5.32 0.96 −0.04 (−0.90,0.81)
SWEMWS T1 −0.39 (−3.19,2.41) 1.37 0.78 −0.09 (−0.81,0.63)
T2 1.22 (−2.28,4.72) 1.68 0.48 0.28 (−0.58,1.14)
BDI-II T1 4.74 (−2.36,11.83) 3.47 0.18 0.39 (−0.34,1.11)
T2 0.80 (−7.56,9.16) 4.01 0.84 0.07 (−0.79,0.92)
FFMQ-SF
TOTAL T1 5.99 (−1.6,17.44) 3.61 0.11 0.53 (−0.20,1.26)
T2 7.92 (−1.6,17.4) 4.56 0.10 0.70 (−0.18,1.59)
Observing T1 1.65 (−0.32,3.61) 0.96 0.10 0.44 (−0.28,1.17)
T2 1.16 (−1.87,4.2) 1.46 0.43 0.31 (−0.53,1.16)
Describing T1 0.37 (−1.99,2.72) 1.15 0.75 0.09 (−0.62,0.81)
T2 0.83 (−1.39,3.05) 1.07 0.45 0.21 (−0.63,1.05)
Acting with Awareness T1 0.55 (−1.91,3.02) 1.21 0.65 0.12 (−0.59,0.84)
T2 1.26 (−1.48,3.99) 1.31 0.35 0.28 (−0.56,1.12)
Non-Judging T1 1.91 (−0.99,4.81) 1.42 0.19 0.62 (−0.11,1.36)
T2 2.32 (−1.95,6.59) 2.05 0.27 0.76 (−0.13,1.64)
Non-reacting T1 1.14 (−1.64,3.92) 1.36 0.41 0.39 (−0.33,1.12)
T2 1.58 (−1.68,4.85) 1.57 0.321 0.55 (−0.31,1.40)
OBQ-44
Total T1 11.53 (−23.22,46.28) 16.94 0.501 0.28 (−0.47,1.02)
T2 6.96 (−34.46,48.38) 19.72 0.73 0.17 (−0.74,1.07)
Responsibility/Threat Estimation T1 0.83 (−13.77,15.44) 7.13 0.91 0.04 (−0.69,0.77)
T2 −3.05 (−22.37,16.27) 9.23 0.75 −0.15 (−1.03,0.73)
Perfectionism/Certainty T1 9.09 (−4.61,22.78) 6.69 0.19 0.43 (−0.31,1.16)
T2 2.46 (−13.16,18.08) 7.49 0.75 0.12 (−0.74,0.97)
Importance/Control of thoughts T1 1.87 (−9.16,12.9) 5.39 0.73 0.12 (−0.61,0.85)
T2 8.86 (−7.12,24.84) 7.68 0.26 0.57 (−0.28,1.43)
Note: Yale-Brown Obsessive Compulsive Scale Second Edition (YBOCS-II), Short Warwick-Edinburgh Mental Well-being Scale (SWEMWB), Beck Depression Inventory
– second edition (BDI-II), Five Facets of Mindfulness Questionnaire – short form (FFMQ-SF), Obsessional Beliefs Questionnaire – 44 item version (OBQ-44); Standard
Deviation (SD); Post therapy (T1), 6 months follow-up (T2); Conﬁdence interval (CI)
a In interpreting the direction of eﬀects, a negative Cohen’s d would show that outcomes numerically favour MB-ERP in comparison to ERP for the following
measures: Y-BOCS-II, BDI-II and OBQ-44. A positive Cohen’s d would show that outcomes numerically favour MB-ERP in comparison to ERP for SWEMWS and FFMQ-
SF scores.
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people to accept intrusive thoughts elicited during ERP tasks and to
remain engaged with the task. Second, it was expected, that teacher-
guided mindfulness practice would enable people to fully attend to and
accept physical sensations of anxiety that occur during ERP and,
therefore, to remain fully engaged with the tasks. Third, because
mindfulness practice places emphasis on bringing awareness to beha-
vioural choices, MB-ERP was expected to enable people to recognise
urges to engage in compulsive behaviours and choose to resist them.
Findings from this study do not support these suggestions.
It could be argued that insuﬃcient opportunity for participants to
cultivate mindfulness in the MB-ERP groups, may explain the lack of
apparent eﬀects on OCD symptom severity. Indeed, time devoted to
mindfulness practice and discussion in each session was considerably
less than in MBCT. Only 30min were devoted to mindfulness practice
and discussion in each MB-ERP session (ﬁve h in total). This is far less
than in MBCT, where the majority of 16–20 therapy hours is spent
practicing mindfulness and discussing learning from mindfulness
practice (Segal et al., 2013). In addition, mindfulness practices in MB-
ERP were shorter (15min maximum) than in MBCT (30min max-
imum). Therefore, there was perhaps simply insuﬃcient attention given
to cultivating mindfulness in the current study.
Whilst these caveats are important to note, the between-group im-
provements in mindfulness for MB-ERP compared to ERP are of interest.
Despite a reduced focus and time spent on mindfulness practice and
discussion compared to MBCT, between-group diﬀerences in improve-
ments in mindfulness were in the medium range at post-therapy
(d=0.53) and large range at six-months follow-up (d=0.70). These
between-group eﬀect sizes on self-reported mindfulness compare fa-
vourably with a meta-analysis of RCTs of MBIs that reported a medium
between-group eﬀect on mindfulness (Hedges g=0.47) (Visted,
Vøllestad, Nielsen, & Nielsen, 2015) and with ﬁndings that MBIs with
brief mindfulness practices can be of clinical beneﬁt (Strauss, Luke,
Hayward, & Jones, 2015). This suggests, (with the caveat that this is a
pilot trial) that MB-ERP compared to ERP has the potential to improve
mindfulness whilst not improving OCD symptom severity or mechan-
isms of OCD-related beliefs. This challenges the theoretical notion that
improving mindfulness should improve OCD symptoms by enabling
non-judgemental acceptance of intrusive thoughts, non-judgemental
acceptance of bodily sensations of anxiety and greater choice in re-
sponding to compulsive urges (Strauss, Luke, et al., 2015).
On average, participants attended 6.5 of the ten group sessions, with
little diﬀerence in this rate between treatment arms. In order to max-
imise engagement with each intervention, and in line with the treat-
ment protocols, if a participant missed a session they were contacted by
phone by one of the group facilitators immediately after the session to
explore reasons for missing the session and to identify and plan daily
ERP tasks. In the MB-ERP arm this also included an exploration of ex-
periences of home mindfulness practice and an encouragement to
continue with mindfulness practice at home. In future studies further
eﬀorts to improve session attendance should be included such as
holding groups in venues that minimise the need for participant travel.
4.2. Strengths and limitations
Strengths of this study include its design. Randomisation was con-
ducted independently and post-therapy assessments were conducted
blind to allocation. Moreover, and unusually for a study of psycholo-
gical therapy, participants were blind to study hypotheses, thus redu-
cing a common potential source of bias. The trial protocol ensures
transparency in publication.
Limitations of this study also pertain to its design. This is a pilot
study, underpowered to detect statistically signiﬁcant eﬀects and liable
to biases inherent in small sample sized studies. Despite this, it is pos-
sible to draw conclusions about the primary hypotheses as the 95%
conﬁdence intervals for the between-group eﬀect on OCD symptom
severity at post-intervention did not include the MCID. This means, that
a deﬁnitive trial would be highly unlikely to ﬁnd that MB-ERP is more
eﬀective than ERP at improving OCD symptom severity. The design
however does mean that we need to be cautious in over-interpreting
ﬁndings on other outcomes where conﬁdence intervals are wide and
cross zero. Another limitation is that no formal measure of intervention
acceptability was included. Whist rates of intervention engagement
were similar between the two treatment arms, which could be taken as
a proxy indicator of intervention acceptability, future research should
include a formal measure. A further limitation was that participants in
the ERP arm of the study received more therapist-assistant ERP time
than MB-ERP participants as a proportion of each MB-ERP session was
devoted to mindfulness practice and inquiry. Whilst the addition of
mindfulness practice and inquiry was explicitly to improve engagement
with ERP, the reduced time spent on ERP tasks may have contributed to
the ﬁndings. Finally, study retention at follow-up was 65%, lower than
expected. It is possible that this has led to a biased account of eﬀects at
follow-up if retained participants were those who had better outcomes.
Future studies should include methods for improving study retention
including maintaining contact with participants during the follow-up
period, paying participants for their time to complete assessments and
having the option to complete assessments online and so avoid the need
for participants to travel.
4.3. Clinical implications
In the context of a proliferation in interest in mindfulness, evidence
from our study suggests that adding mindfulness to ERP (at least in the
way it was done in this study) may not improve symptom severity
compared to ERP alone. Findings suggest that whilst MBIs may have
much to oﬀer people experiencing a range of mental health diﬃculties,
we should not abandon well-established, well-evidenced interventions.
In short, we recommend that current guidelines for OCD are followed;
that people with OCD are given access to ERP with or without cognitive
therapy (American Psychiatric Association, 2007; National Institute of
Health and Care Excellence [NICE], 2005). This is not to rule out the
possibility that MB-ERP may have beneﬁts over ERP for sub-groups of
people with OCD and future qualitative and quantitative research could
explore this given the theoretical rationale for adding a mindfulness-
based approach to ERP.
4.4. Implications
It would be premature to abandon research exploring the potential
of learning mindfulness for people experiencing OCD based on the
ﬁndings of this pilot trial for a number of reasons. As noted above, the
amount of time devoted to mindfulness practice and discussion was
much reduced compared to well-established interventions such as
MBCT. Although the point estimate on between-group diﬀerences in
mindfulness suggested that MB-ERP can lead to improvements in
mindfulness relative to ERP, the 95% conﬁdence interval for this eﬀect
crossed zero meaning that this point estimate must be treated cau-
tiously. Future research should examine the eﬀects of cultivating
mindfulness for OCD using a more intensive approach, perhaps based
on the well-established MBCT protocol, but adapting this for OCD. In
addition, whilst speculative, it may be the case that ERP and MB-ERP
are eﬀective for diﬀerent groups of people with OCD. Whilst the current
study does not allow an exploration of participant moderators of out-
come, qualitative research of MB-ERP may help to elucidate if this in-
tervention has greater potential for subgroups of people with OCD in
comparison to ERP. Finally, therapy format (group versus individual)
may have a bearing on eﬀectiveness. Whilst group ERP is recommended
for OCD (National Institute of Health and Care Excellence [NICE],
2005), an individual approach has potential advantages in terms of
more closely tailoring the treatment plan to the participant, more clo-
sely monitoring participant progress and facilitating disclosure of
shame-related OCD thoughts and beliefs. Future research could explore
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the potential of MB-ERP delivered in individual format where such
factors could be attended to.
4.5. Conclusions
Although underpowered to draw deﬁnitive conclusions, ﬁndings
from this pilot RCT suggest that adding a brief mindfulness-based in-
tervention to ERP may not lead to clinically meaningful improvements
in OCD symptom severity outcomes compared to ERP alone.
Furthermore, ﬁndings suggest that improvements in mindfulness may
not translate into improvements in OCD symptom severity. Clinical
implications are to underline the importance of adhering to current
treatment guidelines and to continue to oﬀer ERP to people with OCD.
Further research is now needed to investigate if a greater focus on
cultivating mindfulness and decoupling learning mindfulness from an
explicit focus ERP has potential, in addition to exploring participant-
level moderators of therapy outcome (i.e. that diﬀerent approaches may
lead to better outcomes for diﬀerent people). It is important not to
abandon work in this area based on ﬁndings from the current pilot
study, particularly given the sound theoretical reasons why cultivating
mindfulness might have much to oﬀer people struggling with OCD.
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